126 related articles for article (PubMed ID: 32354931)
1. A Simple Implement for Assessing the Survival of Elderly Patients With Melanoma Irradiated for Cerebral Metastases.
Nguyen T; Janssen S; Schild SE; Rades D
In Vivo; 2020; 34(3):1361-1364. PubMed ID: 32354931
[TBL] [Abstract][Full Text] [Related]
2. The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer.
Rades D; Nguyen T; Schild SE
In Vivo; 2020; 34(3):1317-1320. PubMed ID: 32354924
[TBL] [Abstract][Full Text] [Related]
3. Performance Status Is Associated With Survival in Elderly Patients Irradiated for Cerebral Metastases from Prostate Cancer.
Nguyen T; Bartscht T; Schild SE; Rades D
Anticancer Res; 2020 Mar; 40(3):1665-1668. PubMed ID: 32132072
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors After Whole-brain Radiotherapy Alone for Brain Metastases from Malignant Melanoma.
Rades D; Sehmisch L; Janssen S; Schild SE
Anticancer Res; 2016 Dec; 36(12):6637-6640. PubMed ID: 27919995
[TBL] [Abstract][Full Text] [Related]
5. Shorter-course whole-brain radiotherapy for brain metastases in elderly patients.
Rades D; Evers JN; Veninga T; Stalpers LJ; Lohynska R; Schild SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e469-73. PubMed ID: 21477949
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
7. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
[TBL] [Abstract][Full Text] [Related]
8. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM.
Rades D; Sehmisch L; Hansen HC; Dziggel L; Janssen S; Schild SE
Anticancer Res; 2019 Mar; 39(3):1501-1505. PubMed ID: 30842188
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial.
Hong AM; Fogarty GB; Dolven-Jacobsen K; Burmeister BH; Lo SN; Haydu LE; Vardy JL; Nowak AK; Dhillon HM; Ahmed T; Shivalingam B; Long GV; Menzies AM; Hruby G; Drummond KJ; Mandel C; Middleton MR; Reisse CH; Paton EJ; Steel V; Williams NC; Scolyer RA; Morton RL; Thompson JF
J Clin Oncol; 2019 Nov; 37(33):3132-3141. PubMed ID: 31553661
[TBL] [Abstract][Full Text] [Related]
12. Short-course whole-brain radiotherapy (WBRT) for brain metastases due to small-cell lung cancer (SCLC).
Bohlen G; Meyners T; Kieckebusch S; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Rades D
Clin Neurol Neurosurg; 2010 Apr; 112(3):183-7. PubMed ID: 19962229
[TBL] [Abstract][Full Text] [Related]
13. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
14. Remaining Lifespan of Patients Aged ≥65 Years Receiving Whole-brain Irradiation for Metastases from Cancer of Unknown Primary.
Rades D; Nguyen T; Khoa MT; Janssen S; Schild SE
Anticancer Res; 2020 Apr; 40(4):2261-2264. PubMed ID: 32234923
[TBL] [Abstract][Full Text] [Related]
15. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
16. An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer.
Rades D; Nguyen T; Janssen S; Schild SE
Anticancer Res; 2020 Apr; 40(4):2257-2260. PubMed ID: 32234922
[TBL] [Abstract][Full Text] [Related]
17. A New Diagnosis-Specific Survival Score for Patients to be Irradiated for Brain Metastases from Non-small Cell Lung Cancer.
Rades D; Hansen HC; Schild SE; Janssen S
Lung; 2019 Jun; 197(3):321-326. PubMed ID: 30927058
[TBL] [Abstract][Full Text] [Related]
18. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
[TBL] [Abstract][Full Text] [Related]
20. Whole-brain radiotherapy in patients with brain metastases from melanoma.
de la Fuente M; Beal K; Carvajal R; Kaley TJ
CNS Oncol; 2014 Nov; 3(6):401-6. PubMed ID: 25438811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
